Imatinib Terminated Phase 2 Trials for Thyroid Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00115739Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma